Back
Protara Therapeutics 10K Form
Sell
32
TARA
Protara Therapeutics
Last Price:
2.97
Seasonality Move:
-6.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TARA News And Ratings
See the #1 stock for the next 7 days that we like better than TARA
TARA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-8.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.01 |
| Price / Book: | 0.52 |
Profitability
| EPS (TTM): | -3.57000 |
|---|---|
| Net Income (TTM): | $-40.42M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Protara Therapeutics Earnings Forecast
Key Protara Therapeutics Financial Ratios
- The Interest Expense is -1.72% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Protara Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TARA |
| CUSIP: | 74365U |
| Website: | protaratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TARA Technical Analysis vs Fundamental Analysis
Sell
32
Protara Therapeutics (TARA)
is a Sell
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a Sell
The current Protara Therapeutics [TARA] share price is $3.10. The Score for TARA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.